-
1 month ago | 
lupusnewstoday.com | Patricia Inacio |Steve Bryson |Katherine Poinsatte |Andrea Lobo
The U.S. Food and Drug Administration (FDA) has agreed to review an application by Roche seeking approval of obinutuzumab for the treatment of lupus nephritis, a lupus complication marked by kidney inflammation and damage. Developed by Roche’s subsidiary Genentech and Biogen, obinutuzumab is an antibody-based treatment, already approved for certain blood cancers, that was found in a clinical trial to ease symptoms of kidney disease in lupus nephritis patients.
-
2 months ago | 
lupusnewstoday.com | Andrea Lobo |Margarida Maia |Katherine Poinsatte |Steve Bryson
The U.S. Food and Drug Administration (FDA) has granted fast track status to ADI-001, Adicet Bio’s CAR T-cell therapy for systemic lupus erythematosus (SLE) that’s resistant to available treatments, the company announced in a press release. The designation follows the FDA’s award last year of fast track status for lupus nephritis, a common complication of lupus marked by kidney damage and inflammation.
-
Jan 20, 2025 | 
lupusnewstoday.com | Candace J. Semien |Marisa Zeppieri |Kristiana Page |Kellie McRae
Near the end of 2024, the support group Lupus in Color posted the following “lupus serenity prayer” on Instagram:“God, grant me the serenity to accept the changes and challenges of living with lupus, the courage to face each day with strength, and the wisdom to do what’s good for my mind, body, and soul as I seek the support and treatment I need for a healthier life.”This prayer was written by Lupus in Color founder Racquel Dozier. It asks for serenity, courage, and wisdom.
-
Jan 16, 2025 | 
lupusnewstoday.com | Katherine Poinsatte |Margarida Maia |Patricia Inacio |Andrea Lobo
Caribou Biosciences has launched a Phase 1 clinical trial to evaluate the safety and efficacy of CB-010, its CAR T-cell therapy for lupus that affects the kidneys and other organs. CB-010 is being developed as a treatment for people with lupus nephritis, a common complication of lupus that causes kidney damage and inflammation, and those with extrarenal lupus, in which other tissues and organs are affected.
-
Dec 11, 2024 | 
lupusnewstoday.com | Marisa Zeppieri |Marisa Wexler |Candace J. Semien
As another year draws to a close, I find myself reflecting not only on the milestones of the past 12 months, but also on the journey that’s brought me to this moment. When I look back at the years when I was so sick, growing up with unexplainable pain and fatigue, I never imagined I would make it this far. I was just a child when I first began to feel the weight of my illness, and by the time I was diagnosed with lupus in my 20s, the prognosis seemed grim.
-
Nov 27, 2024 | 
lupusnewstoday.com | Marisa Zeppieri |Candace J. Semien
It’s no secret that living with lupus or other chronic illnesses often feels like a constant game of tug-of-war. One part of us aches to chase after our dreams, tackle projects, and seize life, while the other part is continually reminded of the need to slow down, conserve energy, and avoid flares. I often liken it to an emotional and physical seesaw, one that few understand unless they’ve walked our road. The hardest part of this balancing act is the unpredictability.
-
Nov 21, 2024 | 
lupusnewstoday.com | Marisa Wexler |Margarida Maia |Andrea Lobo |Lindsey Shapiro
Treatment with dapirolizumab pegol is better than a placebo at controlling disease activity in people with systemic lupus erythematosus (SLE), according to new results from a Phase 3 clinical trial. UCB and Biogen, the therapy’s developers, shared full results from that trial — which they called “statistically and clinically significant” — in a late-breaking presentation at the American College of Rheumatology’s annual meeting, held Nov.
-
Oct 9, 2024 | 
lupusnewstoday.com | Candace J. Semien |Patricia Inacio |Marisa Zeppieri
Hester Prynne is being condemned for a private act that became a public sin. After being freed from jail, she’s led to stand on a scaffold before a crowd of villagers. She’s holding her 3-month-old baby and wearing an embroidered letter “A” on her cloak, both attesting to what she did. Prynne is the main character in “The Scarlet Letter,”written by Nathaniel Hawthorne and published in 1850. She is a young English woman sent to Puritan Massachusetts to wait for her husband’s arrival.
-
Oct 2, 2024 | 
lupusnewstoday.com | Candace J. Semien |Andrea Lobo |Patricia Inacio |Marisa Zeppieri
More than 20 years ago, Christine Miserandino explained living with systemic lupus erythematosus, the most common form of lupus, as having only a metaphorical “12 spoons” of energy a day. Her spoon theory does a great job of representing the tightrope walk of survival that we endure. The spoon theory became widely known throughout the lupus community, but it doesn’t offer a plan to manage the spoons. However, Bionews columnists and others have offered their survival strategies.
-
Aug 14, 2024 | 
lupusnewstoday.com | Marisa Zeppieri |Patricia Inacio |Candace J. Semien
Whether you’re healthy or living with a chronic illness, navigating a new friendship is always a delicate dance. For those of us with lupus (or possibly multiple autoimmune diseases), it can be difficult to explain why we’re suddenly MIA for days, or even weeks, at a time. Welcome to life with chronic illness, where our social calendar is more unpredictable than a toddler with a crayon.